top of page
the team

Our Research Journey

Decoding ubiquitin signal

We employ a multidisciplinary approach—integrating bioinformatics, X-ray crystallography, biochemistry, biophysics, and bacterial genetic — to elucidate the molecular and cellular mechanisms that decode ubiquitin signals into functional
cellular responses in the brain and other tissues.

TMRK5981.jpg

Our Researchers

TMRK6221.jpg

Prof. Gali Prag

PI

TMRK6236.jpg

Reut Avishid Kohn

Lab manager

TMRK6187.jpg

Amir Florentin

PhD Student

IMG_9960.JPG

Noam Deouell

M.Sc Student

TMRK6218.jpg

Alina Kordonsky

PhD student

TMRK6225_edited.jpg

Taimaa Abd Alkhaleq

M.Sc Student

IMG_9959.JPG

Dr. Elon yariv

PostDoc

Research

Purification of ubiquitylated proteins in E. coli

Ubiquitylation regulates nearly all cellular pathways, buy degradation and deubiquitylation processes make it challenging to isolate ubiquitylated isoforms for detailed biochemical and biophysical studies. Through a synthetic biology approach, we have reconstituted the entire eukaryotic ubiquitylation cascade in E. coli, which lacks deubiquitylases, allowing for the stable accumulation of ubiquitylated proteins. Utilizing two affinity tags—one on ubiquitin and another on the protein of interest—this technique enables efficient purification of modified substrates. Our system produces proteins with native, stable ubiquitin modifications and has facilitated the creation of numerous plasmids containing various E2s, E3s, and substrates. This method consistently yields milligram quantities of highly purified ubiquitylated proteins for downstream biochemical and structural studies.

Ubiquin-receptors

Our research focuses on understanding how ubiquitin (Ub) directs a vast array of cellular processes. Ubiquitylation—the attachment of Ub to specific proteins—requires decoding by hundreds of Ub receptors that translate this signal into targeted cellular responses. These Ub receptors utilize Ub-binding domains (UBDs) tethered to response domains, thereby exerting their functional role upon the ubiquitylated proteins they bind. Interestingly, Ub receptors themselves undergo ubiquitylation, which we propose serves as a regulatory mechanism that inactivates their activity by blocking their UBDs, as illustrated in our research model. Leveraging our bacterial system for ubiquitylated protein purification, we isolated substantial amounts of ubiquitylated Ub receptors suitable for crystallization. Recent crystallographic analysis of a ubiquitylated Ub receptor has offered novel insights into the role of self-ubiquitylation, enriching our understanding of Ub signal regulation

Structural-Based Bioinformatics for Identification of UBDs

We hypothesized that hidden Ub-binding domains (UBDs) may exist within the Protein Data Bank (PDB). To uncover these in silico, we developed a novel structure-based search algorithm. By superimposing UBD complexes from various UBD families, we identified a minimal atomic cluster (highlighted as red and gray mesh balls in E2-25k) that is sufficient for Ub binding. Using this cluster as a signature, we scanned the PDB and observed high scores for known UBDs, alongside unknown potential UBDs such as the ALIX-V domain. Interestingly, ALIX links several critical processes, including apoptosis via ALG-2, ubiquitylated-cargo trafficking at the MVB, cytokinesis, and retrovirus (like HIV) budding. We validated ALIX-V as a bona fide UBD, using Micro Scale Thermophoresis (MST) to quantify binding affinities for both wild-type and mutant ALIX complexes. Functional assays further demonstrated the importance of Ub-binding in retrovirus budding (Keren-Kaplan, Attali et al., EMBO J, 2013). Building on this success, we are applying our algorithm to other protein structures, recently characterizing the Ub-binding sites of the vWA domain of Rpn10 as published in Nature Communications.

Development and Application of the Split-CAT System for Protein-Protein Interaction
and Ubiquitylation Studies

Our research leverages the split-chloramphenicol acetyl transferase (Split-CAT) assay to advance our understanding of protein-protein interactions (PPIs) and ubiquitylation within E. coli. This innovative assay system, built on synthetic biology principles, enables efficient detection of PPIs and ubiquitylation through the assembly of split-CAT fragments, which confer antibiotic resistance upon reconstitution.

TMRK5953.jpg

Publictions

E. coli-Based Selection and Expression Systems for Discovery, Characterization, and Purification of Ubiquitylated Proteins

Structure of ubiquitylated-Rpn10 provides insight into its autoregulation mechanism

Ubiquitylation‐dependent oligomerization regulates activity of Nedd4 ligases

Split Chloramphenicol Acetyl-Transferase Assay Reveals Self-Ubiquitylation-Dependent Regulation of UBE3B

Patents

01.

Chloramphenicol resistant split protein and uses thereof

 


Gali Prag
US Patent 11,932,846

02.

Systems and method for screening small molecules of interest


Gali Prag
US Patent Application 17/285,133

03.

Bacterial systems for analyzing ubiquitylated polypeptides

 

 


Gali Prag
US Patent Application 17/207,943

04.

Bacterial systems for analyzing ubiquitylated polypeptides

 

 

Gali Prag
US Patent 10,982,252

Contact Us

The Prag Lab - Tel-Aviv University

Department of Biochemistry and Molecular Biology

Sherman 612

Tel Aviv University

69978

Tel aviv, ISRAEL

prag@tauex.tau.ac.il

Telephone   Office        +972 3   640-9828 

Telephone   X-ray lab   +972 3   640-6435

Telephone   Wet lab.    +972 3   640-9828

Cell phone                    +972 54 256-0198

Fax                               +972 3   640-6834

Based on Prag Lab's work, Coletac Therapeutics was founded.  This company exemplifies how innovative research within a university setting can successfully transition into a thriving commercial enterprise.  The foundation of Coletac Therapeutics lies in the pioneering work conducted at the Prag Lab at Tel-Aviv University, led by Professor Gali Prag.

bottom of page